Whistleblower's Cephalon FCA Suit Headed To Pa. Court

Law360, Los Angeles (March 19, 2014, 8:17 PM EDT) -- A New York federal judge on Wednesday agreed to move a whistleblower suit alleging Cephalon Inc. promoted some of its drugs for off-label uses to boost sales to government-funded programs, finding that a similar suit in Pennsylvania was filed first.

U.S. District Judge Sidney H. Stein granted plaintiff Matthew Cestra’s motion to move the suit, agreeing that the suit is substantially similar to the Pennsylvania suit alleging the drugmaker had submitted hundreds of thousands of false claims to federal and state health care programs, according to...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.